Nexus Surgical Faces Evaluation Adjustment Amid Flat Financial Performance and Stock Underperformance
Nexus Surgical and Medicare, a microcap in the NBFC sector, has experienced a recent score adjustment amid flat financial performance for the quarter ending June 2025. Despite a year-over-year profit increase, the stock has underperformed against the BSE500 index, raising concerns about its long-term fundamentals.
Nexus Surgical and Medicare, a microcap player in the Non-Banking Financial Company (NBFC) sector, has recently undergone an adjustment in evaluation, reflecting a revision in its score. The company reported flat financial performance for the quarter ending June 2025, indicating a lack of significant movement in key metrics during this period.Despite a reported 28% increase in profits over the past year, the stock has generated a return of -11.28%, suggesting a disconnect between profit growth and stock performance. The company's operating profits have shown a compound annual growth rate (CAGR) of 2.83%, which raises questions about its long-term fundamental strength. Additionally, with a return on equity (ROE) of 52.8 and a price-to-book value of 8.4, the valuation appears elevated compared to historical averages.
Nexus Surgical's stock is trading at a discount relative to its peers, yet it has underperformed against the BSE500 index over various time frames, including the last three years, one year, and three months. The majority of shareholders are non-institutional, which may influence the stock's market dynamics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
